Literature DB >> 3038311

Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.

L M Nutter, S P Grill, J S Li, R S Tan, Y C Cheng.   

Abstract

Phorbol esters and n-butyrate (SB) together could induce Epstein-Barr virus (EBV) DNA polymerase and DNase activities in Raji cells (virus nonproducer). Neither 12-O-tetradecanoylphorbol-13-acetate (TPA) nor SB alone could induce these EBV enzyme activities, transcription of the EcoRI C-region or other EBV proteins in Raji cells. The enzyme induction caused by exposure of Raji cells to TPA-SB was the result of the synthesis of virus-specified RNA, and the increase of linear EBV DNA content in Raji cells caused by TPA alone was not sufficient for induction of EBV-enzyme activities. Temporal characteristics of the TPA-SB induction process, but not the phorbol 12,13-dibutyrate-SB induction process, in Raji cells were observed; a critical phase (10-24 h) postphorbol ester treatment in phorbol 12,13-dibutyrate-SB-treated Raji cells which was responsible for the synthesis of virus RNA and enzymes was found. Phospholipase C, which increases intracellular diacylglycerols (and subsequently activates protein kinase C) was able to partially substitute for TPA in the TPA-SB induction for EBV polymerase and DNase activities. Sphingosine, a protein kinase C inhibitor, partially prevented the induction of virus enzyme activities in Raji cells treated with phorbol 12,13-dibutyrate and SB. No apparent changes in the methylation state of EBV DNA (EcoRI C region) were observed when Raji cells were treated with SB and TPA, alone or in combination. These results suggest that induction of EBV polymerase and DNase activities by TPA-SB may involve protein kinase C activation and another factor triggered by SB which together increase transcription of EBV DNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038311

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.

Authors:  L K Chang; S T Liu
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  Regulation of the Epstein-Barr virus DNA polymerase gene.

Authors:  F B Furnari; M D Adams; J S Pagano
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria.

Authors:  S Asai; Y Nakamura; M Yamamura; H Ikezawa; I Namikawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture.

Authors:  G Q Yao; C H Tsai; Y C Cheng
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

5.  Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.

Authors:  C Liu; N D Sista; J S Pagano
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.

Authors:  H B Jenson; G M Grant; Y Ench; P Heard; C A Thomas; S G Hilsenbeck; M P Moyer
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

7.  Identification and some properties of a unique DNA polymerase from cells infected with human B-lymphotropic virus.

Authors:  A R Bapat; A J Bodner; R C Ting; Y C Cheng
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  The role of lipoproteins in EBV early antigen induction in Raji cells.

Authors:  M Simon; I Melzner; B Bültmann
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  TREX1 acts in degrading damaged DNA from drug-treated tumor cells.

Authors:  Chuan-Jen Wang; Wing Lam; Scott Bussom; Hua-Mei Chang; Yung-Chi Cheng
Journal:  DNA Repair (Amst)       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.